Abstract
High-Intensity Focused Ultrasound (HIFU) represents an emerging minimally invasive treatment modality for prostate cancer. This technology employs focused ultrasound waves to ablate prostate tissue, offering a precise and targeted strategy for the management of localized prostate cancer. The present paper aims to deliver a comprehensive review of HIFU, encompassing its technology, advantages, risks, patient selection criteria, and post-treatment monitoring.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
